Project Grant HT94252510004
Award Date
1/1/25
Completion Date
12/31/26
Dollars Obligated
$462K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
The Albert Einstein College of Medicine was awarded a $2,688,000 Project Grant from the Department of the Army Medical Command to investigate the role of pericytes in the pressure-overloaded heart. This award is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Over the four-year period from July...
The Department of the Army Medical Command has awarded a $3,292,001 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Albert Einstein College of Medicine in Bronx, New York. The grant, effective June 1, 2025 through May 31, 2029, will fund the production of cultured red blood cells to support patients with sickle cell disease. The award leverages the college's expertise in biomedical research, clinical trials, and scientific investigations to...
Albert Einstein College of Medicine (AECOM) was awarded a $672,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on Treatment-Induced Metastasis in Ewing Sarcoma. The two-year grant runs from June 1, 2023 to May 31, 2025 and will support AECOM's investigation into medical solutions for metastatic cancers affecting service members, in line with the program's goals of transforming military...
The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Albert Einstein College of Medicine has been awarded a $882,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a novel targeted drug therapy to treat small cell lung cancer (SCLC). The award will support research activities from June 1, 2024 through May 31, 2027. As a highly experienced recipient of federal research grants and contracts, the college has a track record of conducting biomedical research and...